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receive information about it (p < 0,001). 95.74% of women to arouse the attention on 
breast cancer prevention advertisements. ConClusions: Results show that higher 
graduates are less appear on screening contrary to lower. Rate of self-examination is 
higher if family history of breast cancer known. Based on results, it is important to 
reach women who have not yet participated in preventive performances. The reduced 
activity of people living in cities should be improved, used of advantages of city. 
Important to organize a training program, especially for the correct application of the 
method and breast self-examination with usage of questionnaire.
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objeCtives: The main objective of our study was to assess the knowledge of 
HPV among the female university students in Hungary and also learn their atti-
tudes about the vaccine. Methods: The quantitative cross-sectional question-
naire survey was carried out among female students attending the University of 
Pécs Faculty of Health Sciences. 180 questionnaires were distributed, of which 165 
proved to be evaluable. χ 2-test and t-tests were performed as a statistical method 
besides 95% probability (p< 0.05). The data analysis was performed with SPSS 20.0 
programs. Results: 92% of the women knew the meaning of acronym HPV. 57 % 
of respondent women knew the cause of infection. 79.5% of the women knew about 
the virus causing lip and oral cavity cancer. 37.8% of the participants in the sam-
ple said that “only women”, and 62.2% of them said that “both men and women” 
were affected by the infection. It was known by more women who elderly (χ 2= 5,034, 
p= 0,024) and living in marriage or in partnership (χ 2= 7,415, p= 0,006). To sum up the 
analysis on the issues of HPV, those respondents were considered to be informed 
who responded well for 5 questions of 6 ones. This rate was 21.4% that is 32 partici-
pants of 149 women. 97,3% of respondent women had heard about the vaccination 
against HPV. 15 women of the respondents had HPV vaccination, among them there 
were significantly more single, divorced and widow persons. ConClusions: Overall 
the awareness of human papillomavirus of the students responding is low (21,4%). The 
against HPV vaccination does not happen because of the deficiencies in knowledge 
therefore this program is the most important task.
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objeCtives: To assess patient preference for the currently available bone-targeted 
agents (BTAs) used to prevent skeletal-related events (SREs; commonly defined as 
pathologic fracture, radiation to bone, surgery to bone and spinal cord compres-
sion) in Turkey. Methods: Adult patients with a self-reported physician diagnosis 
of bone metastases secondary to a solid tumor were recruited in several hospi-
tals to complete a pencil and paper discrete-choice experiment survey consisting 
of a series of 10 choices between pairs of hypothetical medication profiles. Each 
profile was defined using five attributes with several levels (based on prescribing 
information): time until first SRE (10,18 and 28 months); time until worsening of 
pain (3, 6 and 10 months); annual risk of osteonecrosis of the jaw (ONJ; 0, 1 and 5%); 
annual risk of renal impairment (0, 4 and 10%); and mode of administration (daily 
oral tablet, or subcutaneous injection, 15-minutes or 120-minute intravenous infu-
sion every 4 weeks). Twelve versions of the 10-questions were sequentially admin-
istrated across participants. A main-effects random parameters logit model was 
estimated. Results: A total of 91 patients were included in the analysis and pro-
vided demographic information. Among the attributes included in the survey, annual 
risk of renal impairment, time until worsening of pain and delaying SREs were the 
three most important attributes, with better levels of outcomes preferred to worse 
levels. Daily oral administration was the preferred mode of administration and there 
was no statistically significant difference between injection and infusion of differ-
ent durations. Annual risk of ONJ was judged by patients to be the least important 
attribute. ConClusions: When considering treatment choices, patients in Turkey 
focused mainly on the risk of renal impairment, the delay of pain worsening and 
delaying SREs.
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wHat matters to PatieNts aNd tHeir Caregivers: usiNg soCial media 
aNd PatieNt forums to oBtaiN valuaBle iNformatioN from a PatieNt 
aNd Carer PersPeCtive
Chalkiadaki C., Martin A.
Evidera, London, UK
objeCtives: The aim of this study was to assess whether social media and disease-
specific patient forums can be valuable sources of information on what matters to 
patients and caregivers about their disease and its management. Methods: We 
investigated the accessibility of such information in breast cancer and schizophrenia. 
General social media websites and forums dedicated to sufferers of the two diseases 
were examined. Results: Breast cancer was more frequently mentioned in general 
social media websites than schizophrenia, with more charities, large organisations 
and fundraising events dedicated to breast cancer. Searches for breast cancer and 
schizophrenia on general social media sites result in hundreds of results, but these are 
mainly posted by advertisers or pharmaceutical companies, or contain non-patient 
opinions or news articles. Patients tend not to discuss their condition openly on 
general social media sites, whereas disease-specific forums contain daily entries on 
the patient experience. While searches within forums lead to fewer results, these are 
function showed a diminished QoL, satisfaction with doctors and nurses is good, 
but not for other hospital and doctors office conditions.
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iNvestigatiNg tHe framiNg-effeCts of risK attriButes iN disCrete 
CHoiCe exPerimeNts: a Pilot study
Vass C.M., Rigby D., Campbell S., Payne K.
University of Manchester, Manchester, UK
objeCtives: To understand how the communication of risk in a discrete choice 
experiment (DCE) affects respondents’ choices. Methods: An online pilot DCE was 
designed to understand the preferences of female members of the public (recruited 
via an internet panel provider) for a breast screening programme described by three 
attributes (probability of detecting a cancer, risk of unnecessary treatment, and out-
of-pocket cost) each with four levels. Two versions were used that presented the 
risk attributes (probability of detecting a cancer and risk of unnecessary treatment 
per 100 women screened) as: (A) a percentage or (B) a percentage and risk image 
(icon array). The DCE was blocked into four surveys, each containing 10 choice sets. 
The design, generated using Ngene, included an internal validity test through the 
inclusion of a dominant choice set. The DCE data were analysed using conditional 
logit models. Results: 62 women completed the DCE (31 for each version A and 
B); all were currently eligible for screening under the current NHS programme. All 
coefficients, but no interactions, were significant and had the expected signs. Of 
the respondents who received the percentages only version, almost 20% failed the 
validity test (compared to only 3% of those who received the risk image). Probability 
of detecting a cancer was the most important attribute. Willingness-to-pay (WTP) 
for an additional cancer detected was £175 for respondents presented with the risk 
image, compared to only £152 in the percentages only group. Similarly, WTP to avoid 
an unnecessary treatment was £59 for respondents presented with the risk image 
compared to only £19 in the percentages only group. ConClusions: This pilot 
study highlights the impact attribute framing can have on respondents’ choices in 
a DCE. The use of risk images also resulted in fewer “irrational” responses implying 
respondents had a greater understanding of the task.
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objeCtives: The guideline on economic evaluations from the Swedish price and 
reimbursement authority (TLV) states that experience-based valuation of QALY 
weights are preferred before a hypothetical valuation. The UK hypothetical EQ-5D 
valuation set [Dolan 1997] has been used so far, but since 2013 an experience-
based “tariff” exists for the general population in Sweden [Burström 2013]. This 
study explores the implications on ICERs by applying the two different value 
sets. Methods: FACT-P mapped EQ-5D responses from patients with mCRPC in 
the AFFIRM trial [Skaltsa 2013; Scher 2012] were converted into utility weights using 
both the hypothetical and experience-based value sets. A Markov cohort cost-utility 
model (with stable, progressed and dead health states) analyzing enzalutamide 
(Xtandi®) vs. best supportive care (BSC) was used for studying the implications 
of applying the different utility weights. Results: As the experience-based value 
set had a more compressed event space, and was therefore less sensitive to QoL 
changes, the “on treatment” utility for Xtandi was 0.03 vs. 0.06 (hypothetical). The 
stable and progressed health states attained utility weights of: 0.688 and 0.603, 
respectively (hypothetical); 0.826 and 0.784, respectively (experienced). The sur-
vival gain with Xtandi vs. BSC in combination with the lower hypothetical health 
state utility weights resulted in a QALY gain of 0.66 vs. 0.75 with the experienced 
weights. With an incremental cost of € 51,100 (€ 1= 9SEK) the resulting ICER was 
€ 77,600 and € 68,200 using the hypothetical and experience-based value sets, respec-
tively. ConClusions: The Swedish experience-based EQ-5D value set generates a 
greater absolute utility but with a more compressed event space compared to the 
UK hypothetical value set. In terms of ICERs, this tends to favour technologies that 
extend survival compared to QoL improving technologies, although Xtandi provides 
both. These implications exert great challenge on Swedish decision makers on how 
the Swedish value set should be implemented.
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objeCtives: Aims to gain knowledge about the rate of breast screening among 
Hungarian women. In addition are they familiar with the concept of self-examina-
tion, with procedure and if so, whether it is used and how often. Also would like to 
develop an educational program based on results, which would target risk groups 
and self-examination and process would receive priority in prevention activities of 
breast cancer. Methods: A descriptive, cross-sectional, prospective and quantitative 
study made with women living in and around Sárvár, Hungary. Inclusion criteria was 
considered the group of women over 45 years. A non-random, convenience sampling 
was applied with 100 women, between January and June, 2013. Data collected with a 
questionnaire of 31 questions. Descriptive statistics with frequency range, Chi2-test 
was performed with Microsoft Excel 2007. Results: There is a significant difference 
between the appearance of screening and the distance from medical centre (p < 0.05). 
A higher proportion of women with higher education recognized therapeutic options 
for breast cancer than those with lower education (p < 0.05). For women where breast 
cancer was diagnosed in family history, 80% of them regularly attend screening. The 
women participate in less complex programs for the prevention, because they did not 
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objeCtives: Instanyl® (fentanyl nasal spray) received European market authorisa-
tion in July 2009 for the management of breakthrough pain in adults already receiv-
ing maintenance opioid therapy for chronic cancer pain, with precise instructions 
on indications for use and dosage. The study objectives were to evaluate patient-
reported misuse, abuse, and diversion of Instanyl® in real-life in France. Methods: 
Cross-sectional observational study of patients with an Instanyl® dispensation from 
a non-hospital pharmacy. An anonymous self-administered questionnaire was dis-
tributed to patients at the time of drug dispensation between 27 July 2011 and 12 
November 2012. The questionnaire collected data on indication, contraindications, 
Instanyl® use, and previous completion of the questionnaire. Results: Among the 
272 eligible questionnaires (at least one item completed in addition to age, gender, 
time since first prescription, and absence of previous completion of the question-
naire), all patients were adult and 95% declared misuse. Among the 160 patients 
who declared having cancer, 94% declared misuse: 76% declared at least one indica-
tion/contraindication misuse and 86% at least one posology misuse. Widening the 
definition of use for breakthrough pain to use for both breakthrough and chronic 
pain in cancer patients, reduced the indication/contraindication misuse (63%), but 
when posology misuse was also considered this did not markedly change overall 
misuse (93%). Abuse of Instanyl® (using the drug for emotional reasons, relaxation, 
or sleep disorders) concerned 21 patients (15 with cancer, and 6 without); diversion 
(passing the drug to another person) concerned 2 patients (1 with cancer and 1 
without). ConClusions: Misuse of Instanyl® was widespread. Nearly half reported 
not to have cancer, and among those who did, only a few used this drug correctly. 
There seems to be a communication deficit as to the proper prescribing of this drug, 
and its proper use when prescribed.
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develoPmeNt of a PatieNt-led eNd of study questioNNaire to 
evaluate tHe exPerieNCe of CliNiCal trial PartiCiPatioN
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objeCtives: Obtaining feedback from participants in clinical trials using a struc-
tured method is a valuable opportunity to identify strengths and weaknesses of 
trial design and conduct, highlight improvement opportunities and provide patient 
insight to help future recruitment. This study aimed to develop a questionnaire 
to provide a structured approach to evaluate patients’ experience of clinical trial 
participation. Methods: A draft questionnaire assessing patients’ experiences 
before, during and after the trial was developed in collaboration with oncology 
patient-advocates before being qualitatively reviewed by individuals who have 
participated in a clinical trial or who have provided support to trial participants. 
A literature review informed these draft concepts. Three interviewer-led focus 
groups involving clinical trial participants (on-going or completed within the last 
12 months) (n≤ 9/group) were conducted to evaluate the concepts, and elicit fur-
ther concepts for questionnaire inclusion. An updated questionnaire was devel-
oped based on combined insights from the focus groups and literature review. 
Content validity of the revised measure was considered using cognitive debrief-
ing interviews (n= 12). This testing aimed to identify the relevance and clarity 
of the instrument. Results: A literature review confirmed the relevance of the 
concepts assessed by the draft questionnaire. Aspects of the draft questionnaire 
included the trial enrolment and consent process, logistics of study participa-
tion and dissemination of results. The focus group participants provided further 
evidence on the relevance of the concepts included in the draft instrument and 
the importance of capturing the clinical trial experience from the patient perspec-
tive. Cognitive debriefing results are also presented. ConClusions: The results 
provide evidence to support the content validity of the post-trial questionnaire. 
Assessing the clinical trial experience from the patient perspective using a robust 
questionnaire may offer potential to improve trial design and ensure subjects stay 
engaged throughout the trial process.
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PatieNt-rePorted outComes assessed usiNg tHe Breast-q iNstrumeNt 
iN womeN uNdergoiNg Breast reCoNstruCtioN Post-masteCtomy: a 
systematiC literature review
Lee L.J., Milburn C., Macarios D.
LifeCell Corporation, Bridgewater, NJ, USA
objeCtives: Assessing the effects of breast reconstruction (BR) on patient-reported 
outcomes (PRO) is important as BR becomes increasingly common after mastectomy. 
A systematic literature review was conducted to assess the clinical use of a well-
validated PRO instrument, the BREAST-Q (BQ) in women undergoing BR. Methods: 
Searches using PubMed, ScienceDirect, Cochrane Library, and references in plastic 
surgery journals were conducted from when BQ was developed in 2008 to May 2014 
using the term, ‘breast-q OR breastq’. Non-English, reviews, letters, protocols and 
single-patient case reports were excluded. BQ modules unrelated to reconstruction 
(e.g., Augmentation or Reduction) were also excluded. Each BQ scale score ranged 
from 0-100 with a higher score representing better PRO. Results: After applying 
exclusion criteria, 35 studies were retrieved. Majority of studies were conducted in 
North America (54%, 19/35) or Europe (29%, 10/35). Study sample size ranged from 
N= 14 to 7,110 with mean age ranging 46-55 years. When compared to mastectomy 
alone, BR was associated with higher PROs (p< 0.05) however, adjuvant radiotherapy 
was associated with significantly lower PROs than without radiotherapy (p< 0.05). 
Among PRO scales, sexual well-being was consistently low (range: 30-84) and the 
scores of physical well-being and satisfaction with surgeons were consistently high 
(ranges: 68-89 and ≥ 70, respectively). Majority of the studies administered BQ as 
a single administration post-BR. Only 4 studies reported the change from pre- to 
post-BR (Range of change score = -19 to 36). From 3 of 4 studies, the scale with 
the largest Cohen’s d effect size (ES) was psychosocial well-being (ES range: 1.52-
3.83). ConClusions: Our findings suggest that while BQ is widely used, study 
type and method of administration are disparate. Further assessment of the BQ 
much more accessible and informative, and require less filtering through irrelevant 
posts. For example, posts from breast cancer patients typically discuss side effects of 
investigations and treatments and how to manage them, as well as offering emotional 
support. The limitations of using this type of information include the lack of a mecha-
nism to confirm that contributors really do have the relevant disease, although the 
number of “factitious” patients is likely to be small and outweighed by “true” patients 
and caregivers. ConClusions: This study showed that more valuable information 
can be found in patient-to-patient correspondence in forum threads than in general 
social media. Breast cancer patients appear to be more vocal in patient forums than 
schizophrenia patients, possibly due to the stigma attached to mental health prob-
lems. Little was found on what matters to breast cancer caregivers, since patients 
tend to present their own personal experience.
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PatieNt aNd disease CHaraCteristiCs are imPortaNt determiNaNts 
of HealtH-related quality of life of PatieNts witH metastatiC 
reNal Cell CarCiNoma results from a PoPulatioN-Based registry
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objeCtives: Limited data are available on the health-related quality of life (HRQOL) 
of patients with metastatic renal cell carcinoma (mRCC) in daily practice. The aim 
of this study was to estimate HRQOL of patients with mRCC in daily practice, and to 
assess the influence of patient- and disease characteristics, such as comorbidities 
and adverse events on HRQOL. Methods: Patients with mRCC were selected from 
a Dutch population-based registry (PERCEPTION). In this RCC registry, data were col-
lected on patient- and disease characteristics, treatments and adverse events. To 
measure HRQOL, a generic questionnaire (EQ-5D) was used. Multiple linear regres-
sion was used to determine which patient- and disease characteristics were associ-
ated with HRQOL. Results: In this study, 100/465 (21.5%) patients presented with 
or progressed to mRCC. Average age at diagnosis was 62.9 years (range: 40-82) and 
77% was male. Patients with mRCC reported an average EQ-5D utility score of 0.73 
(95%CI: 0.64-0.82) at diagnosis. Two to six months after diagnosis, the average EQ-5D 
utility score was 0.75 (95%CI: 0.66-0.84) (P= 0.319). Multiple linear regression showed 
that presence of comorbidities (> 1), number of metastatic sites (> 1), radiotherapy 
and presence of grade 3 or grade 4 toxicity were significantly associated with a lower 
EQ-5D utility score. Although presence of bone metastases significantly lowered 
the EQ-5D utility score, this factor was not significant after adjustment for other 
factors. ConClusions: This is one of the first studies that provides insights into 
the HRQOL of patients with mRCC in daily practice. In contrast to previous studies, 
this study also identified patient- and disease characteristics that influence HRQOL. 
Presence of comorbidities, number of metastatic sites, radiotherapy and presence of 
severe toxicity related to targeted therapies were significantly associated with HRQOL. 
This information is helpful in correcting EQ-5D utility scores for these characteristics, 
and will be useful in future cost-effectiveness analyses.
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develoPmeNt of a CoNCePtual model for PediatriC oNCology 
results from a review of qualitative researCH literature aNd 
CliNiCiaN iNterviews
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objeCtives: Childhood cancer’s profound effects should be assessed appropriately 
within clinical trials: however, a conceptual model is required to help design appropriate 
measurement strategies. The aim of this study was to develop an initial pediatric oncol-
ogy conceptual model. Methods: Key databases were searched for articles focused on 
qualitative research with children (ages 0-18) with cancer and/or their caregivers. Four 
patient/parent internet forums were reviewed. Telephone interviews with five pediatric 
oncology clinicians were performed. Data were analyzed using grounded theory meth-
ods. Results: 112 qualitative studies were reviewed. Few studies presented data by 
specific cancer type/stage or child age; blogs/clinician interviews provided insights into 
these areas. Across cancer types, but especially for hematological cancers, pain, fatigue, 
and “feeling unwell”/fever were emphasized, as well as impacts on daily function-
ing. For brain tumors, headaches, sudden lack of coordination/balance, blurred vision, 
seizures, vomiting, dizziness and cognition-related impacts on mood and language 
were highlighted. For solid tumors, tumor-location pain often led to related mobility 
and/or functioning problems; clinicians emphasized lymphadenopathy and weight 
loss. Adolescents appeared to be most impacted by cancer, due to their grasp of the 
cancer’s gravity, self-image issues, loss of autonomy, school absences and social life 
limitations. Though patients/parents/clinicians found it difficult to distinguish between 
treatment- and cancer-related symptoms, treatments caused several problems, such 
as neutropenia, changes in appearance, irritability, nausea/vomiting, fatigue and pain. 
Not emphasized by clinicians but reported frequently in literature/blogs, mucositis and 
changes in tastes concerned parents/children. Clinicians strongly emphasized short-
term/long-term/working memory loss and that anxiety contributed to the occurrence/
severity of other side-effects/impacts. ConClusions: Cancer’s impact on children is 
multifaceted and complicated. Issues identified in this review that must be considered 
when designing outcomes strategies are: the child’s age, cancer type and stage, delineat-
ing disease and treatment symptoms/impacts, and short/long term side effects impacts 
on nutrition and development.
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